4//SEC Filing
Randhawa Simrat 4
Accession 0001992260-25-000008
CIK 0001690585other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 9:00 PM ET
Size
28.8 KB
Accession
0001992260-25-000008
Insider Transaction Report
Form 4
Randhawa Simrat
EVP, Head of R&D
Transactions
- Sale
Common Stock
2025-11-13$37.04/sh−42,765$1,584,016→ 22,576 total - Exercise/Conversion
Common Stock
2025-11-14$21.77/sh+37,494$816,244→ 81,781 total - Exercise/Conversion
Common Stock
2025-11-13$17.88/sh+3,529$63,099→ 91,507 total - Sale
Common Stock
2025-11-13$35.80/sh−26,166$936,743→ 65,341 total - Exercise/Conversion
Common Stock
2025-11-14$17.88/sh+40,287$720,332→ 44,287 total - Sale
Common Stock
2025-11-14$38.14/sh−109,031$4,158,442→ 4,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-13−3,529→ 116,471 totalExercise: $17.88Exp: 2034-01-23→ Common Stock (3,529 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-14−37,494→ 62,506 totalExercise: $21.77Exp: 2034-05-22→ Common Stock (37,494 underlying) - Exercise/Conversion
Common Stock
2025-11-13$8.44/sh+83,978$708,774→ 87,978 total - Sale
Common Stock
2025-11-13$37.72/sh−18,576$700,687→ 4,000 total - Exercise/Conversion
Common Stock
2025-11-14$22.07/sh+31,250$689,688→ 113,031 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-13−83,978→ 11,996 totalExercise: $8.44Exp: 2032-06-06→ Common Stock (83,978 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-14−40,287→ 76,184 totalExercise: $17.88Exp: 2034-01-23→ Common Stock (40,287 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-14−31,250→ 118,750 totalExercise: $22.07Exp: 2035-02-03→ Common Stock (31,250 underlying)
Footnotes (8)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.
- [F2]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.48 to $36.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.48 to $37.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.48 to $38.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F6]The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F7]The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F8]The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001992260
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 9:00 PM ET
- Size
- 28.8 KB